Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | AZN | AMGN | GILD | VRTX |
| Company | Adaptimmune Ther ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0666 | 177.67 | 344.38 | 125.85 | 462.17 |
| High | 0.0701 | 177.80 | 345.00 | 126.39 | 464.98 |
| Low | 0.0526 | 173.66 | 334.05 | 122.43 | 450.39 |
| Latest | 0.0549 | 174.93 | 337.60 | 123.76 | 451.63 |
| Change | -0.0098 | -2.96 | -4.06 | -1.69 | -7.36 |
| % Change | -15.15% | -1.66% | -1.19% | -1.35% | -1.60% |
| Volume | 50,777,800 | 1,667,000 | 8,151,000 | 14,348,300 | 2,993,000 |
| 20-Day Average Volume | 127,153,055 | 2,007,240 | 3,032,160 | 8,788,005 | 1,395,540 |
| Previous Close | 0.0647 | 177.89 | 341.66 | 125.45 | 458.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1355 | 181.78 | 341.38 | 128.81 | 442.29 |
| 20-Day Raw Stochastic | 5.66% | 7.14% | 42.31% | 14.99% | 70.31% |
| 20-Day Relative Strength | 40.90 | 40.50 | 47.53 | 40.36 | 54.35 |
| Weighted Alpha | -58.21 | +15.29 | +13.46 | +7.13 | +4.83 |
| Today's Opinion | 88% Sell | 72% Sell | 8% Sell | 72% Sell | 24% Buy |
| Previous Opinion | 88% Sell | 56% Sell | 24% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 56% Sell | 24% Sell | 24% Sell | 24% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.95% since 10/20/25 | -4.03% since 06/11/26 | -4.65% since 06/11/26 | -1.68% since 06/11/26 | +1.48% since 06/11/26 |
| Low | 0.0417 on 10/21/25 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 439.50 on 06/15/26 |
| High | 0.0926 on 10/22/25 | 182.70 on 06/12/26 | 358.30 on 06/15/26 | 128.20 on 06/17/26 | 464.98 on 06/18/26 |
| 1-Month | |||||
| %Chg | -62.65% since 09/26/25 | -4.89% since 05/18/26 | +4.07% since 05/18/26 | -4.56% since 05/18/26 | +3.45% since 05/18/26 |
| Low | 0.0417 on 10/21/25 | 173.65 on 06/18/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 0.2750 on 10/09/25 | 191.50 on 05/21/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 464.98 on 06/18/26 |
| 3-Month | |||||
| %Chg | -84.17% since 07/25/25 | -7.16% since 03/18/26 | -3.95% since 03/18/26 | -12.41% since 03/18/26 | +0.01% since 03/18/26 |
| Low | 0.0403 on 09/08/25 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 0.2750 on 10/09/25 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 464.98 on 06/18/26 |
| 6-Month | |||||
| %Chg | -79.31% since 04/25/25 | -3.47% since 12/18/25 | +4.06% since 12/18/25 | +1.89% since 12/18/25 | +0.95% since 12/18/25 |
| Low | 0.0403 on 09/08/25 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 0.3578 on 07/24/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,551 | 271,300,320 | 182,205,424 | 153,656,704 | 114,625,952 |
| Shares Outstanding, K | 265,052 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 178,030,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -70,810,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 13,680,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -30,340,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 2.49 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/13/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 11/12/25 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.21 | 15.46 | 14.99 | 27.29 |